Our Therapeutic
Areas of Focus
Powered by
TGF-ß science,
inspired by
patients
At Keros, our mission is to innovate therapies
that have the potential to shift the treatment
paradigm for a wide range of patients with
disorders that are linked to dysfunctional
signaling of the transforming growth
factor-beta (TGF-ß) family of proteins.
News
Our Therapeutic
Advancing Novel Therapeutics With a Focus on Cellular Growth & Repair
The transforming growth factor-beta (TGF-β) superfamily is a group of regulatory proteins that is key to the growth, repair and maintenance of blood cells and a number of tissues. Leveraging our deep expertise in TGF-β science, we are focused on developing and commercializing novel therapeutics with the ability to modulate TGF-β signaling and unlock potentially disease-modifying benefits for patients in need.
Working at Keros is More Than
A Job - It's A Mission
What Drives Us
We take our mission personally.
We love our work.
It’s about the science.
We invest in our people.